News

AG’s IP is comprised of T Cells Receptor ("TCR") clonality analysis technology and T Central Memory Cell ("Tcm") and Dendritic Cell ("DC") preparation methodologies. The TCR clonality analysis

The issued patent # 8,846,635 is titled, "Method for inducing hepatocyte proliferation and uses thereof." Can-Fite has recently been granted a patent for this technology in Japan and

The patent, which extends through 2032, provides composition of matter protection for KP511, KemPharm’s prodrug of hydromorphone, and adds to the intellectual property estate governing the company’s pain

This project is part of CDC’s surveillance effort, with the potential to continue up to 5 years. KAI is a full-service Contract Research Organization providing support to both

The acquisition, which will strengthen J&J’s existing pipeline in viral diseases, will include Alios’ portfolio of potential therapeutics for viral infections including compound AL-8176, an orally administered antiviral

The expansion is expected to help the pharmaceutical company in creating about 100 new jobs at its Dortmund site. Boehringer Ingelheim member of the Board of Managing Directors

Dupilumab is an investigational therapy that blocks IL-4 and IL-13 signaling. The results showed that dupilumab met all primary and secondary endpoints in these patients who did not

The trial is designed to assess the efficacy of DanDrit’s vaccine MelCancerVac (MCV) in stage IV CRC patients rendered disease free after the completion of standard treatments in

MAA for nivolumab is the first completed regulatory submission for a PD-1 immune checkpoint inhibitor in this tumor type. Bristol-Myers Squibb senior vice-president and head of Oncology Development